According to a new study, topical calcineurin inhibitors such as pimecrolimus and tacrolimus did not increase risk in AD patients.

An assessment of various types of skin moisturizers suggests an emollient emulsion may be the most effective option to help prevent...

Nearly 90% of 1,651 so-called ‘natural’ personal care products contain at least one known allergen, according to a new study from...

A recent study has shown that AD and bacterial skin infection rates are higher in Indigenous youth compared to non-Indigenous youth.

Adult and pediatric AD patients have experienced more adverse effects after prolonged use of corticosteroids.

An early investigational report indicates that a compound derived from baby spinach leaves may be developed into an effective topical...

Tralokinumab treatment in patients with AD does not increase Covid-19 severity or interfere with Covid-19 vaccinations.

A digitally delivered intervention showed significant improvements in treatment adherence and other clinical outcomes in AD patients.